SELECTIVE UPTAKE OF THE ANTICANCER DRUG BENDAMUSTINE BY LIVER AND KIDNEY TISSUES FOLLOWING ITS INTRAVENOUS ADMINISTRATION TO MICE

Citation
S. Bezek et al., SELECTIVE UPTAKE OF THE ANTICANCER DRUG BENDAMUSTINE BY LIVER AND KIDNEY TISSUES FOLLOWING ITS INTRAVENOUS ADMINISTRATION TO MICE, Methods and findings in experimental and clinical pharmacology, 18(2), 1996, pp. 117-122
Citations number
14
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
03790355
Volume
18
Issue
2
Year of publication
1996
Pages
117 - 122
Database
ISI
SICI code
0379-0355(1996)18:2<117:SUOTAD>2.0.ZU;2-C
Abstract
Distribution of C-14-bendamustine following intravenous (i.v.) adminis tration to mice was examined by whole body autoradiographic (WBAR) and quantitative techniques. The WBAR study showed that C-14-bendamustine -derived radioactivity was distributed extremely unevenly at each time interval investigated. After 5 min of administration the highest dens ity of radioactive material was found in the liver and in the kidney. At all time intervals investigated the brain remained free of the leve l. In a detailed quantitative distribution study it was found that C-1 4-bendamustine-derived radioactivity was also unevenly distributed thr oughout the mouse tissues. At 5 min postdosing the level of C-14 was b y one order higher in the liver and in the kidney in comparison to the lungs, heart, spleen, and muscle. The results of both WBAR adn quanti tative tissue distribution studies suggest that bendamustine was selec tively taken up from the blood by liver and kidney tissues. Because of this pharmacokinetic property, does modification should be taken into consideration when administering the drug to patients suffering from hepatobilary and kidney disorders.